Engineers Gate Manager LP Acquires Shares of 7,715 athenahealth (ATHN)

Engineers Gate Manager LP acquired a new position in shares of athenahealth (NASDAQ:ATHN) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 7,715 shares of the health services provider’s stock, valued at approximately $1,103,000.

Several other large investors also recently bought and sold shares of the company. Alliancebernstein L.P. increased its holdings in shares of athenahealth by 1.8% during the 4th quarter. Alliancebernstein L.P. now owns 22,790 shares of the health services provider’s stock worth $3,032,000 after purchasing an additional 400 shares during the period. Amalgamated Bank boosted its position in shares of athenahealth by 5.7% during the 4th quarter. Amalgamated Bank now owns 7,892 shares of the health services provider’s stock valued at $1,050,000 after acquiring an additional 427 shares in the last quarter. Daiwa Securities Group Inc. boosted its position in shares of athenahealth by 1.1% during the 1st quarter. Daiwa Securities Group Inc. now owns 56,125 shares of the health services provider’s stock valued at $8,028,000 after acquiring an additional 589 shares in the last quarter. Fox Run Management L.L.C. boosted its position in shares of athenahealth by 19.2% during the 4th quarter. Fox Run Management L.L.C. now owns 4,412 shares of the health services provider’s stock valued at $587,000 after acquiring an additional 712 shares in the last quarter. Finally, Peregrine Capital Management LLC boosted its position in shares of athenahealth by 0.6% during the 4th quarter. Peregrine Capital Management LLC now owns 144,442 shares of the health services provider’s stock valued at $19,217,000 after acquiring an additional 904 shares in the last quarter.

In other athenahealth news, CEO Jonathan Bush sold 5,000 shares of the business’s stock in a transaction dated Tuesday, May 1st. The shares were sold at an average price of $124.01, for a total value of $620,050.00. Following the completion of the transaction, the chief executive officer now directly owns 340,106 shares of the company’s stock, valued at $42,176,545.06. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Jeffrey R. Immelt bought 7,200 shares of the company’s stock in a transaction on Tuesday, February 20th. The stock was bought at an average cost of $138.44 per share, with a total value of $996,768.00. Following the completion of the purchase, the director now owns 678 shares of the company’s stock, valued at approximately $93,862.32. The disclosure for this purchase can be found here. Over the last ninety days, insiders sold 48,431 shares of company stock valued at $7,084,565. Insiders own 2.90% of the company’s stock.

Several analysts have recently weighed in on ATHN shares. Canaccord Genuity lifted their target price on shares of athenahealth from $123.00 to $137.00 and gave the company a “hold” rating in a research report on Thursday, February 1st. ValuEngine lowered shares of athenahealth from a “hold” rating to a “sell” rating in a research report on Friday, February 2nd. Royal Bank of Canada reiterated a “hold” rating and set a $152.00 target price on shares of athenahealth in a research report on Friday, February 2nd. BidaskClub lowered shares of athenahealth from a “sell” rating to a “strong sell” rating in a research report on Saturday, February 3rd. Finally, SunTrust Banks lifted their target price on shares of athenahealth to $180.00 and gave the company a “buy” rating in a research report on Monday, February 5th. One investment analyst has rated the stock with a sell rating, eighteen have assigned a hold rating and eight have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $151.35.

athenahealth opened at $150.01 on Monday, MarketBeat.com reports. The stock has a market capitalization of $6.06 billion, a price-to-earnings ratio of 58.14, a PEG ratio of 2.79 and a beta of 1.16. athenahealth has a 12 month low of $111.61 and a 12 month high of $158.66. The company has a current ratio of 2.71, a quick ratio of 2.71 and a debt-to-equity ratio of 0.25.

athenahealth (NASDAQ:ATHN) last released its quarterly earnings results on Thursday, April 26th. The health services provider reported $1.25 EPS for the quarter, beating the Zacks’ consensus estimate of $0.72 by $0.53. The firm had revenue of $329.40 million for the quarter, compared to analyst estimates of $318.13 million. athenahealth had a net margin of 6.77% and a return on equity of 13.01%. The company’s revenue for the quarter was up 15.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.32 earnings per share. research analysts predict that athenahealth will post 2.92 earnings per share for the current fiscal year.

athenahealth Company Profile

athenahealth, Inc, together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services.

Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply